Viewing Study NCT06729593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-04-11 @ 6:47 PM
Study NCT ID: NCT06729593
Status: COMPLETED
Last Update Posted: 2025-10-09
First Post: 2024-12-10
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None COVID 19 View
None Coronaviridae Infections View
None Coronavirus Infections View
None RNA Virus Infections View
None Virus Diseases View
None Nidovirales Infections View
None SARS-CoV-2 View
None SARS Coronavirus View
None ACTIV-3 View
None ACTIV3 View